BSAI
BLUSKY AI INC.
$4.65
+11.24%
No data for this timeframe.
Vol
SEC Reports1
Recent Activity
May 22, 2026
SEC
BluSky AI appointed Theodore P. Botts to fill a board vacancy and entered into director and indemnification agreements w
8-K — Impact 2/10
Jan 16, 2026
Insider
Gay Danny Lane sold 200,000 shares
Chief Operating Officer @ $0.00 ($0.00)
Jan 16, 2026
Insider
D'Ambrosio Trent sold 300,000 shares
CEO/CFO @ $0.0100 ($3.0K)
Apr 1, 2025
Insider
Gay Danny Lane sold 200,000 shares
Chief Operating Officer @ $0.00 ($0.00)
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jan 16, 2026 | Gay Danny | G | $0.00 |
| Jan 16, 2026 | D'Ambrosio Trent | G | $3.0K |
| Apr 1, 2025 | Gay Danny | A | $0.00 |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
2 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 16, 2026 | Gay Danny Lane | Chief Operating Officer | G | 200,000 | $0.00 | $0.00 |
| Jan 16, 2026 | D'Ambrosio Trent | CEO/CFO | G | 300,000 | $0.0100 | $3.0K |
| Apr 1, 2025 | Gay Danny Lane | Chief Operating Officer | A | 200,000 | $0.00 | $0.00 |
1 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 2.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2021-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jan 1, 2022 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Dec 1, 2021 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Nov 1, 2021 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Oct 1, 2021 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.